glp 1 while nursing GLP-1 Breastfeeding: Safety & Clinical Guidance – PlexusDx GLP-1 Medications and Breastfeeding

Patients often describe it as finally unlocking the last five percent helping them feel lighter tighter and more in control of cravings without the heavy or sluggish sensation associated with full therapeutic doses

Polycystic Ovarian Syndrome: Correlation Between Hyperandrogenism, Insulin Resistance and Obesity

What You Need to Know About Orforglipron t2diabetesnetwork Apr 1 4 min read Updated: May 19 Written by Clare Koning, RN, PhD T2D Network | April 2026 | 6 min read Key Highlights Orforglipron is a once-daily GLP-1 pill: no injections, no food or water timing restrictions Phase 3 trials showed A1C reductions of 1.3%1.6% and meaningful weight loss In a head-to-head trial published in The Lancet , it outperformed oral semaglutide on every key endpoint Regulatory submissions are underway in 40+ countries: U.S

Eligibility focuses on treating the underlying medical condition rather than weight alone

Liraglutide (Victoza, Saxenda), administered once daily, has an intermediate half-life of approximately 13 hours and typically clears from the body within 3 days (about 5 half-lives) of discontinuation

Metformin is also often prescribed to treat prediabetes and polycystic ovary syndrome (PCOS)